Yu Xie, MD
Advanced Heart Failure and Transplant Cardiology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 3 carriers
- Offices
- 10
Offices
10 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · Sequoia Hospital · Sutter Santa Rosa Regional Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Xie’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A118086 · Current
Licensed to practise in California · since 2011 · expires 2027-04-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Santa Rosa Regional HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.157, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Sutter Santa Rosa Regional Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.157 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,147 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.69 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.53 (108.3 to 216.76) · 54 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 316 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 296 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,971 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.06 to 0.47) · 4,946 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,974 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.99 (2.93 to 7.06) · 1,288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0 to 3.15) · 532 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (0.82 to 3.9) · 1,214 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.87 (2.35 to 17.39) · 558 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.01 (4.29 to 11.73) · 522 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 337 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.89) · 4,064 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.626 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.299 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 342 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.1 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14 · 352 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.4 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 309 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5.1 to 9.8) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8.8 to 15) · 259 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.8 to 18) · 1,275 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 702 cases | No different | Jan 2024 – Dec 2024 |
What patients said (752 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$229,160
Medicare paid this office $229,160 for 614 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 53 | $78,920 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $32,756 | $105 |
| Long return visit (40+ min) | 116 | $30,306 | $153 |
| Long return visit (40+ min) | 106 | $23,821 | $123 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $15,847 | $135 |
See all 21 services
| Critical care, first 30-74 minutes | 53 | $78,920 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $32,756 | $105 |
| Long return visit (40+ min) | 116 | $30,306 | $153 |
| Long return visit (40+ min) | 106 | $23,821 | $123 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $15,847 | $135 |
| Evaluation of lower heart chamber assist device | 45 | $9,060 | $34 |
| New patient visit (60+ min) | 39 | $7,671 | $197 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 68 | $5,491 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 314 | $4,277 | $13 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,155 | $143 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $3,861 | $241 |
| Biopsy of heart muscle | 12 | $3,628 | $191 |
| New patient visit (60+ min) | 11 | $1,780 | $162 |
| Ultrasound of heart with probe in esophagus to assess heart pump function | 16 | $1,506 | $89 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 43 | $925 | $22 |
| Ultrasound of heart, follow-up | 21 | $572 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 42 | $498 | $12 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $224 | $20 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $162 | $6 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $141 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $33 | $3 |
Who their Medicare patients are
614 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 11% · Women 50% · Also on Medicaid 16% · Health risk score 1.57. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 2.53.
Conditions among them: High blood pressure 75% · Coronary heart disease 47% · Heart failure 35% · Chronic kidney disease 33% · Diabetes 30% · Atrial fibrillation 30% · Depression 18% · Cancer 17% · COPD 12% · Stroke 6% · Dementia 5%.
The office billed $1,051,483, Medicare allowed $296,274 and paid $229,160; for 2,326 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 614 | 2,326 | 74 | 1.57 | $1,051,483 | $229,160 |
| 2023 | 453 | 1,911 | 73 | 1.84 | $885,073 | $201,895 |
| 2022 | 378 | 1,391 | 74 | 1.76 | $594,782 | $140,573 |
| 2021 | 452 | 1,754 | 73 | 1.87 | $723,943 | $175,355 |
| 2020 | 360 | 1,303 | 73 | 2.00 | $505,069 | $121,064 |
| 2019 | 217 | 1,383 | 71 | 2.57 | $618,905 | $147,897 |
| 2018 | 66 | 320 | 69 | 3.21 | $127,716 | $32,977 |
| 2014 | 39 | 70 | 70 | 3.69 | $21,987 | $7,189 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Critical care, first 30-74 minutes | 43 | $64,140 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $29,573 | $107 |
| Long return visit (40+ min) | 92 | $29,201 | $157 |
| Long return visit (40+ min) | 99 | $21,263 | $125 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 105 | $14,277 | $126 |
| Evaluation of lower heart chamber assist device | 44 | $10,922 | $35 |
| New patient visit (60+ min) | 43 | $8,683 | $202 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,350 | $157 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 46 | $3,306 | $60 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $3,280 | $219 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 173 | $2,231 | $12 |
| New patient visit (60+ min) | 11 | $1,807 | $164 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 21 | $1,255 | $60 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 23 | $565 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 23 | $307 | $13 |
2022: 11 services
| Critical care, first 30-74 minutes | 35 | $38,559 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $27,896 | $95 |
| Long return visit (40+ min) | 68 | $20,815 | $154 |
| Long return visit (40+ min) | 63 | $17,823 | $128 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 59 | $8,361 | $123 |
| Evaluation of lower heart chamber assist device | 26 | $5,756 | $34 |
| New patient visit (60+ min) | 28 | $5,322 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,099 | $178 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 39 | $2,737 | $64 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 36 | $2,240 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 155 | $2,080 | $12 |
2021: 14 services
| Critical care, first 30-74 minutes | 39 | $50,371 | $194 |
| Long return visit (40+ min) | 90 | $28,775 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 54 | $26,455 | $93 |
| Long return visit (40+ min) | 76 | $24,182 | $159 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $8,877 | $107 |
| Evaluation of lower heart chamber assist device | 30 | $7,174 | $34 |
| New patient visit (60+ min) | 26 | $5,383 | $207 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $5,219 | $180 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $3,988 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 191 | $2,664 | $13 |
| New patient visit (60+ min) | 11 | $1,680 | $153 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 42 | $1,321 | $31 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 19 | $495 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 21 | $353 | $16 |
2020: 13 services
| Critical care, first 30-74 minutes | 34 | $36,169 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $20,953 | $93 |
| Long return visit (40+ min) | 67 | $15,599 | $98 |
| Evaluation of lower heart chamber assist device | 30 | $8,624 | $43 |
| Long return visit (40+ min) | 34 | $7,632 | $123 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $7,398 | $121 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,701 | $181 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $3,585 | $68 |
| New patient visit (60+ min) | 19 | $3,560 | $187 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 137 | $2,248 | $16 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 49 | $589 | $12 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 12 | $296 | $25 |
| Ultrasonic guidance for blood vessel access | 12 | $249 | $13 |
2019: 12 services
| Critical care, first 30-74 minutes | 59 | $57,035 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $26,826 | $91 |
| Long return visit (40+ min) | 54 | $12,208 | $95 |
| Evaluation of lower heart chamber assist device | 27 | $9,607 | $40 |
| Long return visit (40+ min) | 49 | $9,513 | $130 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $6,580 | $64 |
| Biopsy of heart muscle | 14 | $6,462 | $190 |
| New patient visit (60+ min) | 30 | $5,513 | $184 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,759 | $179 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $3,658 | $203 |
| Ultrasonic guidance for blood vessel access | 19 | $522 | $12 |
| Analysis of data from ct study of heart blood vessels to assess severity of heart artery disease, anatomical data review | 32 | $377 | $12 |
2018: 5 services
| Critical care, first 30-74 minutes | 13 | $10,096 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $5,651 | $93 |
| Long return visit (40+ min) | 24 | $4,048 | $99 |
| Evaluation of lower heart chamber assist device | 13 | $2,272 | $41 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $1,714 | $66 |
2014: 3 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,522 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,400 | $80 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,128 | $87 |
Medicaid work
$17,729 in 2024
Medicaid paid $17,729 for 163 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 109 | $14,084 |
| Long return visit (40+ min) | 38 | $2,151 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 16 | $1,494 |
| 2024 | 163 | 3 | 18 | $17,729 |
| 2023 | 390 | 4 | 20 | $37,599 |
| 2022 | 87 | 2 | 14 | $5,793 |
| 2021 | 25 | 1 | 13 | $1,857 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 123 | $16,193 |
| Long return visit (40+ min) | 132 | $12,509 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 120 | $7,907 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $990 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 59 | $3,014 |
| Long return visit (40+ min) | 28 | $2,779 |
2021
| Long return visit (40+ min) | 25 | $1,857 |
Drugs they prescribed that Part D paid
$1,350,164
Pharmacies billed $1,350,164 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,809) in 2024. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 0%.
1,447 generic and fewer than 11 brand-name prescriptions · $1,350,164 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndamax | 36 | $897,145 | $24,921 |
| Entresto | 91 | $108,742 | $1,195 |
| Eliquis | 70 | $87,721 | $1,253 |
| Camzyos | 12 | $85,883 | $7,157 |
| Farxiga | 48 | $47,588 | $991 |
See all 30 drugs
| Vyndamax | 36 | $897,145 | $24,921 |
| Entresto | 91 | $108,742 | $1,195 |
| Eliquis | 70 | $87,721 | $1,253 |
| Camzyos | 12 | $85,883 | $7,157 |
| Farxiga | 48 | $47,588 | $991 |
| Jardiance | 37 | $36,047 | $974 |
| Xarelto | 20 | $21,246 | $1,062 |
| Repatha Sureclick | 19 | $20,455 | $1,077 |
| Metoprolol | 209 | $3,535 | $17 |
| Bumetanide | 57 | $3,421 | $60 |
| Tacrolimus | 14 | $2,955 | $211 |
| Atorvastatin | 186 | $2,022 | $11 |
| Rosuvastatin | 101 | $1,471 | $15 |
| Ezetimibe | 25 | $1,054 | $42 |
| Losartan | 91 | $806 | $9 |
| Amlodipine Besylate | 111 | $794 | $7 |
| Potassium Chloride | 31 | $779 | $25 |
| Hydralazine | 41 | $742 | $18 |
| Pantoprazole | 44 | $738 | $17 |
| Furosemide | 82 | $533 | $7 |
| Valsartan | 15 | $487 | $32 |
| Lisinopril | 52 | $424 | $8 |
| Pravastatin | 43 | $417 | $10 |
| Warfarin | 30 | $401 | $13 |
| Spironolactone | 47 | $362 | $8 |
| Carvedilol | 45 | $288 | $6 |
| Simvastatin | 16 | $163 | $10 |
| Metoprolol | 25 | $138 | $6 |
| Isosorbide Mononitrate Er | 15 | $125 | $8 |
| Allopurinol | 21 | $65 | $3 |
Year by year
| 2024 | 1,809 | 243 | 0% (0) | None | $1,350,164 |
| 2023 | 1,633 | 218 | 0% (0) | 14% | $923,540 |
| 2022 | 1,393 | 181 | 0% (0) | 16% | $902,698 |
| 2021 | 1,232 | 170 | None | None | $428,583 |
| 2020 | 762 | 108 | None | 19% | $593,660 |
| 2019 | 618 | 83 | None | 21% | $364,613 |
| 2018 | 195 | 64 | None | None | $23,321 |
| 2017 | 338 | 68 | 0% (0) | 44% | $38,171 |
| 2016 | 204 | 48 | 0% (0) | None | $12,011 |
| 2015 | 91 | 18 | 0% (0) | 30% | $10,251 |
| 2014 | 40 | 12 | None | 33% | $3,060 |
| 2013 | 12 | None | None | 0% | $85 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Vyndamax | 18 | $598,603 | $33,256 |
| Eliquis | 70 | $82,667 | $1,181 |
| Entresto | 57 | $58,981 | $1,035 |
| Farxiga | 34 | $30,023 | $883 |
| Xarelto | 14 | $15,554 | $1,111 |
| Tacrolimus | 18 | $6,859 | $381 |
| Metoprolol | 230 | $5,213 | $23 |
| Bumetanide | 45 | $5,184 | $115 |
| Atorvastatin | 207 | $3,064 | $15 |
| Omega-3 Acid Ethyl Esters | 21 | $2,076 | $99 |
| Potassium Chloride | 32 | $1,698 | $53 |
| Rosuvastatin | 62 | $1,394 | $22 |
| Losartan | 87 | $1,299 | $15 |
| Amlodipine Besylate | 123 | $1,148 | $9 |
| Hydralazine | 42 | $1,124 | $27 |
| Pantoprazole | 40 | $883 | $22 |
| Warfarin | 33 | $796 | $24 |
| Pravastatin | 51 | $642 | $13 |
| Doxycycline Hyclate | 11 | $545 | $50 |
| Ezetimibe | 11 | $524 | $48 |
| Lisinopril | 39 | $516 | $13 |
| Isosorbide Mononitrate Er | 12 | $442 | $37 |
| Carvedilol | 25 | $429 | $17 |
| Furosemide | 59 | $406 | $7 |
| Spironolactone | 26 | $343 | $13 |
| Allopurinol | 18 | $281 | $16 |
| Prednisone | 16 | $256 | $16 |
| Metoprolol | 14 | $135 | $10 |
| Sulfamethoxazole-Trimethoprim | 14 | $134 | $10 |
| Simvastatin | 11 | $129 | $12 |
2022: 22 drugs
| Vyndamax | 34 | $705,894 | $20,762 |
| Eliquis | 56 | $60,803 | $1,086 |
| Entresto | 44 | $45,461 | $1,033 |
| Farxiga | 21 | $17,025 | $811 |
| Bumetanide | 57 | $6,977 | $122 |
| Metoprolol | 209 | $4,249 | $20 |
| Atorvastatin | 140 | $2,519 | $18 |
| Rosuvastatin | 34 | $1,629 | $48 |
| Hydralazine | 60 | $1,500 | $25 |
| Pantoprazole | 49 | $1,189 | $24 |
| Warfarin | 46 | $1,017 | $22 |
| Potassium Chloride | 27 | $1,001 | $37 |
| Losartan | 82 | $856 | $10 |
| Amlodipine Besylate | 89 | $691 | $8 |
| Isosorbide Mononitrate Er | 30 | $562 | $19 |
| Lisinopril | 59 | $450 | $8 |
| Pravastatin | 20 | $370 | $19 |
| Furosemide | 40 | $327 | $8 |
| Spironolactone | 25 | $322 | $13 |
| Carvedilol | 14 | $197 | $14 |
| Metoprolol | 13 | $97 | $7 |
| Hydrochlorothiazide | 13 | $37 | $3 |
2021: 25 drugs
| Vyndamax | 16 | $302,424 | $18,902 |
| Eliquis | 31 | $28,566 | $921 |
| Entresto | 33 | $24,766 | $750 |
| Xarelto | 12 | $17,414 | $1,451 |
| Bumetanide | 57 | $7,854 | $138 |
| Valganciclovir | 18 | $3,087 | $171 |
| Metoprolol | 127 | $2,347 | $18 |
| Atorvastatin | 105 | $1,561 | $15 |
| Pantoprazole | 51 | $1,391 | $27 |
| Potassium Chloride | 40 | $1,253 | $31 |
| Hydralazine | 50 | $1,094 | $22 |
| Pravastatin | 39 | $898 | $23 |
| Warfarin | 60 | $891 | $15 |
| Losartan | 56 | $612 | $11 |
| Isosorbide Mononitrate Er | 32 | $581 | $18 |
| Finasteride | 12 | $517 | $43 |
| Amlodipine Besylate | 53 | $405 | $8 |
| Lisinopril | 73 | $397 | $5 |
| Rosuvastatin | 13 | $347 | $27 |
| Furosemide | 63 | $332 | $5 |
| Levothyroxine | 19 | $327 | $17 |
| Spironolactone | 23 | $312 | $14 |
| Gabapentin | 13 | $269 | $21 |
| Simvastatin | 16 | $149 | $9 |
| Metoprolol | 13 | $56 | $4 |
2020: 19 drugs
| Vyndaqel | 16 | $298,760 | $18,673 |
| Entresto | 24 | $15,917 | $663 |
| Eliquis | 14 | $13,567 | $969 |
| Mycophenolic Acid | 13 | $4,313 | $332 |
| Bumetanide | 17 | $2,147 | $126 |
| Metoprolol | 53 | $1,806 | $34 |
| Potassium Chloride | 31 | $912 | $29 |
| Pantoprazole | 53 | $910 | $17 |
| Pravastatin | 37 | $797 | $22 |
| Warfarin | 40 | $762 | $19 |
| Atorvastatin | 39 | $567 | $15 |
| Losartan | 34 | $501 | $15 |
| Lisinopril | 50 | $433 | $9 |
| Hydralazine | 18 | $364 | $20 |
| Amiodarone | 11 | $306 | $28 |
| Furosemide | 52 | $284 | $5 |
| Prednisone | 14 | $270 | $19 |
| Amlodipine Besylate | 28 | $148 | $5 |
| Glipizide | 14 | $53 | $4 |
2019: 19 drugs
| Vyndaqel | 15 | $289,370 | $19,291 |
| Valganciclovir | 16 | $14,767 | $923 |
| Eliquis | 13 | $11,912 | $916 |
| Entresto | 11 | $7,389 | $672 |
| Bumetanide | 28 | $2,705 | $97 |
| Metoprolol | 27 | $1,152 | $43 |
| Pantoprazole | 34 | $654 | $19 |
| Potassium Chloride | 25 | $652 | $26 |
| Atorvastatin | 31 | $591 | $19 |
| Warfarin | 30 | $500 | $17 |
| Pravastatin | 26 | $464 | $18 |
| Prednisone | 26 | $374 | $14 |
| Furosemide | 40 | $318 | $8 |
| Lisinopril | 31 | $297 | $10 |
| Amlodipine Besylate | 26 | $237 | $9 |
| Gabapentin | 12 | $235 | $20 |
| Carvedilol | 15 | $222 | $15 |
| Nystatin | 11 | $167 | $15 |
| Sulfamethoxazole-Trimethoprim | 21 | $113 | $5 |
2018: 3 drugs
| Eliquis | 12 | $5,511 | $459 |
| Atorvastatin | 14 | $334 | $24 |
| Furosemide | 16 | $87 | $5 |
2017: 9 drugs
| Pradaxa | 43 | $18,155 | $422 |
| Atorvastatin | 50 | $1,809 | $36 |
| Bisoprolol | 25 | $863 | $35 |
| Furosemide | 21 | $414 | $20 |
| Metoprolol | 28 | $296 | $11 |
| Losartan | 12 | $224 | $19 |
| Carvedilol | 17 | $194 | $11 |
| Lisinopril | 19 | $193 | $10 |
| Amlodipine Besylate | 12 | $91 | $8 |
2016: 7 drugs
| Pradaxa | 13 | $4,395 | $338 |
| Atorvastatin | 34 | $1,279 | $38 |
| Bisoprolol | 14 | $596 | $43 |
| Clopidogrel | 14 | $324 | $23 |
| Furosemide | 19 | $267 | $14 |
| Carvedilol | 12 | $136 | $11 |
| Lisinopril | 11 | $132 | $12 |
2015: 3 drugs
| Eliquis | 11 | $3,625 | $330 |
| Atorvastatin | 11 | $391 | $36 |
| Lisinopril | 14 | $54 | $4 |
Money from drug and device companies
$625 in 2025
| 2025 | 6 | 6 | None | $625 |
| 2024 | 7 | 8 | None | $473 |
| 2023 | 1 | 1 | None | $28 |
| 2022 | 2 | 4 | None | $113 |
| 2021 | 4 | 11 | None | $337 |
| 2020 | 9 | 11 | None | $367 |
| 2019 | 15 | 48 | None | $1,691 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $343 | 1 payment
|
| Medtronic | Corevalve Evolut R | $154 | 1 payment
|
| Paragonix Technologies | Sherpapak | $44 | 1 payment
|
| Pfizer | Vyndaqel | $31 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $28 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $26 | 1 payment
|
See all 6 published payments
| Medtronic | Meals · 2025-12-19 | Corevalve Evolut R | $154 |
| Pfizer | Meals · 2025-12-08 | Vyndaqel | $31 |
| Paragonix Technologies | Meals · 2025-10-01 | Sherpapak | $44 |
| Heartflow | Meals · 2025-06-26 | Ffrct | $343 |
| Alnylam Pharmaceuticals | Meals · 2025-05-29 | Onpattro | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-11 | None | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $473
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $177 | 2 payments
|
| Impulse Dynamics (USA) | Optimizer | $129 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $44 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $42 | 1 payment
|
| CVRx | Barostim Neo System | $32 | 1 payment
|
| One Lambda | None | $29 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $21 | 1 payment
|
2023: $28
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $28 | 1 payment
|
2022: $113
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $100 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $13 | 1 payment
|
2021: $337
| Abbott Laboratories | Heartmate 3 Left Ventricular Assist Device | $202 | 6 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $100 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
| HeartFlow | Ffrct | $17 | 1 payment
|
2020: $367
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $177 | 2 payments
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $48 | 2 payments
|
| Alnylam Pharmaceuticals | Onpattro | $28 | 1 payment
|
| Amgen | Repatha | $23 | 1 payment
|
| HeartFlow | None | $21 | 1 payment
|
| CathWorks | Ffrangio System | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
| iRhythm Technologies | Zio Patch | $16 | 1 payment
|
2019: $1,691
| Medical Device Business Services | Carto 3 System | $715 | 11 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $245 | 6 payments
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Dev | $177 | 7 payments
|
| Pfizer | Vyndaqel | $134 | 5 payments
|
| Amgen | Repatha | $93 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $70 | 4 payments
|
| Actelion Pharmaceuticals US | Uptravi | $55 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $34 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $33 | 2 payments
|
| HeartFlow | None | $32 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $29 | 1 payment
|
| Astellas Pharma US | Lexiscan | $24 | 1 payment
|
| Lundbeck | Northera | $22 | 1 payment
|
| iRhythm Technologies | Zio Patch | $15 | 1 payment
|
| Boston Scientific | Watchman | $13 | 1 payment
|
Professional record
- NPI
- 1295044808
- Licence
- CA A118086California A118086: Current · expires 2027-04-30
- Trained
- University of California, San Francisco School of Medicine, 2010
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RA0001X (207RA0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2010-09-29
- NPI last updated
- 2020-06-03
- NPI record certified
- 2020-06-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3350 La Jolla Village Dr, San Diego, CA, 92161